UPClytics
View all cases

UPC APP 32529/2025

EP3691518 · BIOTELEMETRY DEVICE THAT CAN BE INGESTED AND IMPLANTED IN VIVO

Case details
Status
Claim dismissed
Action
Appeal (EPO decision)
Category
Appeal (EPO decision)
Parties
Claimants
Representatives
Respondents
  • EPOOther / unknown
Division
Milan CD
Technology
  • Instruments
    Medical technology
Language
—
First decided
Aug 6, 2025
How this compares
How long the court takes to reach a first decision.
Median days to first decision
All UPC124
Milan CDLocked
Judge Andrea PostiglioneLocked

At the UPC: Bodycap (3 cases)·EPO (5 cases)

This dispute contains 1 other proceedings

UPC CoA 796/2025

1 other defendants litigating the same or a related patent

UPC CFI 628/2025

Start a free trial to see how each one ended.

More cases: Milan CD·2025

Decisions
  • 2025-08-06
    Action against the decision of the EPO (RoP97)Public

    Summary: Order of Central Division Milan Section (duty judge, in French) dismissing Bodycap, CNRS and Université de Rennes' appeal (under R. 97 RoP) against the EPO's rejection of their unitary effect request for EP 3 691 518. The EPO had correctly applied R. 6.2 and R. 7.3 of the Implementing Regulations for Unitary Protection (RPU): after the university reorganisation (Université de Rennes I dissolved and replaced by Université de Rennes), the new address had not been provided in the unitary effect application within the one-month non-extendable deadline under R. 7.3 RPU. Each party bears its own costs.

    Show the legal issues (4)
    • Action against EPO decision on unitary effect under R. 97 RoP
    • Unitary effect application: correct address requirement under R. 6.2 RPU
    • Non-extendable one-month deadline under R. 7.3 RPU
    • University reorganisation – change of applicant entity
Documents
  • C86024AFC32AF06BA29C018CD60484C5_fr.pdf2025-08-06FR